Page 171 - Pro-active Management of Women’s Health after Cardiometabolic Complicated Pregnancies

3.5 Feasibility and effectiveness of a lifestyle intervention| 169 Figure 3.5.3c. Biochemical changes during the study period
Total cholesterol (mmol/l)
Intervention group Controls 84 LDL-cholesterol (mmol/l)
HDL-cholesterol (mmol/l)
5,4 5,2 5,0 4,8 4,6 4,4 4,2 4,0
4,4 4,2 4,0 3,8 3,6 3,4 3,2 3,0
6,0 5,8 5,6 5,4 5,2 5,0 4,8 4,6 4,4 4,2 4,0
300 250 200 150 100 50
3,852 3,4
3,3
78
3,2
3,716
1,6 1,4 1,2 1,0 0,8 0,6 0,4 0,2 0,0
9,0 8,0 7,0 6,0 5,0 4,0 3,0 2,0 1,0 0,0
100 90 80 70 60 50 40 30 20 10 0
250 200 150 100 50
80
6 months
10 months
13 months
6 months
6 months
10 months
10 months
13 months
13 months
6 months
10 months
CRP (mg/l)
10 months
13 months
Total/HDL-cholesterol
Triglycerides (mmol/l)
3,0
74
2,9
72
2,8
2,7 2,68 2,5
1,6 1,4 1,2 1,0 0,8 0,6 0,4 0,2 0,0
7,0 6,0 5,0 4,0 3,0 2,0 1,0 0,0
18 16 14 12 10 8 6 4 2
70
6 months
10 months
13 months
6 months
10 months
13 months
6 months
13 months
Fasting Glucose (mmol/l)
75g-OGTT 2h Glucose (mmol/l)
DM2-criteria (%)
6 months
10 months
13 months
6 months
10 months
13 months
6 months
10 months
13 months
HOMA2-score (%S)
Urinary PC-ratio (g/mol)
Urinary protein loss (mg/24h)
000 6 months 10 months 13 months 6 months 10 months 13 months
6 months
10 months
13 months